SafeBeat Rx
PrivateLast Round
Grant
Sep 17, 2024
Est. Valuation
$1.79M
Total Funding Raised
$2.71M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
SafeBeat Rx is a healthtech company that develops artificial intelligence-based software for remote cardiac patient monitoring and therapeutic guidance.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Telemedicine, Health IoT, Patient Engagement
Business Model
B2B2C
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SafeBeat Rx Comparables
Compare SafeBeat Rx with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AccurKardia | 81% | |
| Anumana | 76% | |
| RhythmScience Inc. | 75% |
SafeBeat Rx Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 17, 2024 | ||||
| Grant | Aug 5, 2024 | ||||
| Accelerator | Oct 9, 2022 | ||||
| Angel | Jul 3, 2022 | ||||
| Accelerator | Jun 7, 2022 | ||||
Seed | Sep 1, 2021 |
Key People
Founding team and executive leadership
SafeBeat Rx Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Zillionize | Seed |
| Fusion Fund | Seed |
| MedTech Innovator | Accelerator |
| NIH RADx | Grant |
| HeartX Accelerator | Accelerator |
| Y Combinator | Seed |
| HealthTech Arkansas | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 116% MoM.
- Jan 15, 2026
Grew 16% QoQ from 38 to 44 employees.
SafeBeat Rx Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about SafeBeat Rx's valuation, stock price, and market status.
Is SafeBeat Rx a public or private company?
SafeBeat Rx is a private company.
What is the current stock price of SafeBeat Rx?
SafeBeat Rx is a private company with no public stock price. No recent secondary market data is available.
How much is SafeBeat Rx worth (valuation)?
SafeBeat Rx's valuation is estimated at $1.8M based on funding round data.
Can I buy SafeBeat Rx stock?
SafeBeat Rx shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was SafeBeat Rx's last funding round?
SafeBeat Rx's most recent funding round was Grant on August 31, 2021.
Who are the main investors in SafeBeat Rx?
Key investors in SafeBeat Rx include National Heart, Lung, and Blood Institute.
Will SafeBeat Rx IPO soon?
No public IPO plans have been announced for SafeBeat Rx.
How can I track SafeBeat Rx secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor SafeBeat Rx's secondary market activity and sign up for updates.